Cargando…
Radiogenomic modeling predicts survival-associated prognostic groups in glioblastoma
BACKGROUND: Combined whole-exome sequencing (WES) and somatic copy number alteration (SCNA) information can separate isocitrate dehydrogenase (IDH)1/2-wildtype glioblastoma into two prognostic molecular subtypes, which cannot be distinguished by epigenetic or clinical features. The potential for rad...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883769/ https://www.ncbi.nlm.nih.gov/pubmed/33615222 http://dx.doi.org/10.1093/noajnl/vdab004 |
_version_ | 1783651280113106944 |
---|---|
author | Nuechterlein, Nicholas Li, Beibin Feroze, Abdullah Holland, Eric C Shapiro, Linda Haynor, David Fink, James Cimino, Patrick J |
author_facet | Nuechterlein, Nicholas Li, Beibin Feroze, Abdullah Holland, Eric C Shapiro, Linda Haynor, David Fink, James Cimino, Patrick J |
author_sort | Nuechterlein, Nicholas |
collection | PubMed |
description | BACKGROUND: Combined whole-exome sequencing (WES) and somatic copy number alteration (SCNA) information can separate isocitrate dehydrogenase (IDH)1/2-wildtype glioblastoma into two prognostic molecular subtypes, which cannot be distinguished by epigenetic or clinical features. The potential for radiographic features to discriminate between these molecular subtypes has yet to be established. METHODS: Radiologic features (n = 35 340) were extracted from 46 multisequence, pre-operative magnetic resonance imaging (MRI) scans of IDH1/2-wildtype glioblastoma patients from The Cancer Imaging Archive (TCIA), all of whom have corresponding WES/SCNA data. We developed a novel feature selection method that leverages the structure of extracted MRI features to mitigate the dimensionality challenge posed by the disparity between a large number of features and the limited patients in our cohort. Six traditional machine learning classifiers were trained to distinguish molecular subtypes using our feature selection method, which was compared to least absolute shrinkage and selection operator (LASSO) feature selection, recursive feature elimination, and variance thresholding. RESULTS: We were able to classify glioblastomas into two prognostic subgroups with a cross-validated area under the curve score of 0.80 (±0.03) using ridge logistic regression on the 15-dimensional principle component analysis (PCA) embedding of the features selected by our novel feature selection method. An interrogation of the selected features suggested that features describing contours in the T2 signal abnormality region on the T2-weighted fluid-attenuated inversion recovery (FLAIR) MRI sequence may best distinguish these two groups from one another. CONCLUSIONS: We successfully trained a machine learning model that allows for relevant targeted feature extraction from standard MRI to accurately predict molecularly-defined risk-stratifying IDH1/2-wildtype glioblastoma patient groups. |
format | Online Article Text |
id | pubmed-7883769 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-78837692021-02-18 Radiogenomic modeling predicts survival-associated prognostic groups in glioblastoma Nuechterlein, Nicholas Li, Beibin Feroze, Abdullah Holland, Eric C Shapiro, Linda Haynor, David Fink, James Cimino, Patrick J Neurooncol Adv Basic and Translational Investigations BACKGROUND: Combined whole-exome sequencing (WES) and somatic copy number alteration (SCNA) information can separate isocitrate dehydrogenase (IDH)1/2-wildtype glioblastoma into two prognostic molecular subtypes, which cannot be distinguished by epigenetic or clinical features. The potential for radiographic features to discriminate between these molecular subtypes has yet to be established. METHODS: Radiologic features (n = 35 340) were extracted from 46 multisequence, pre-operative magnetic resonance imaging (MRI) scans of IDH1/2-wildtype glioblastoma patients from The Cancer Imaging Archive (TCIA), all of whom have corresponding WES/SCNA data. We developed a novel feature selection method that leverages the structure of extracted MRI features to mitigate the dimensionality challenge posed by the disparity between a large number of features and the limited patients in our cohort. Six traditional machine learning classifiers were trained to distinguish molecular subtypes using our feature selection method, which was compared to least absolute shrinkage and selection operator (LASSO) feature selection, recursive feature elimination, and variance thresholding. RESULTS: We were able to classify glioblastomas into two prognostic subgroups with a cross-validated area under the curve score of 0.80 (±0.03) using ridge logistic regression on the 15-dimensional principle component analysis (PCA) embedding of the features selected by our novel feature selection method. An interrogation of the selected features suggested that features describing contours in the T2 signal abnormality region on the T2-weighted fluid-attenuated inversion recovery (FLAIR) MRI sequence may best distinguish these two groups from one another. CONCLUSIONS: We successfully trained a machine learning model that allows for relevant targeted feature extraction from standard MRI to accurately predict molecularly-defined risk-stratifying IDH1/2-wildtype glioblastoma patient groups. Oxford University Press 2021-02-15 /pmc/articles/PMC7883769/ /pubmed/33615222 http://dx.doi.org/10.1093/noajnl/vdab004 Text en © The Author(s) 2021. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Basic and Translational Investigations Nuechterlein, Nicholas Li, Beibin Feroze, Abdullah Holland, Eric C Shapiro, Linda Haynor, David Fink, James Cimino, Patrick J Radiogenomic modeling predicts survival-associated prognostic groups in glioblastoma |
title | Radiogenomic modeling predicts survival-associated prognostic groups in glioblastoma |
title_full | Radiogenomic modeling predicts survival-associated prognostic groups in glioblastoma |
title_fullStr | Radiogenomic modeling predicts survival-associated prognostic groups in glioblastoma |
title_full_unstemmed | Radiogenomic modeling predicts survival-associated prognostic groups in glioblastoma |
title_short | Radiogenomic modeling predicts survival-associated prognostic groups in glioblastoma |
title_sort | radiogenomic modeling predicts survival-associated prognostic groups in glioblastoma |
topic | Basic and Translational Investigations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883769/ https://www.ncbi.nlm.nih.gov/pubmed/33615222 http://dx.doi.org/10.1093/noajnl/vdab004 |
work_keys_str_mv | AT nuechterleinnicholas radiogenomicmodelingpredictssurvivalassociatedprognosticgroupsinglioblastoma AT libeibin radiogenomicmodelingpredictssurvivalassociatedprognosticgroupsinglioblastoma AT ferozeabdullah radiogenomicmodelingpredictssurvivalassociatedprognosticgroupsinglioblastoma AT hollandericc radiogenomicmodelingpredictssurvivalassociatedprognosticgroupsinglioblastoma AT shapirolinda radiogenomicmodelingpredictssurvivalassociatedprognosticgroupsinglioblastoma AT haynordavid radiogenomicmodelingpredictssurvivalassociatedprognosticgroupsinglioblastoma AT finkjames radiogenomicmodelingpredictssurvivalassociatedprognosticgroupsinglioblastoma AT ciminopatrickj radiogenomicmodelingpredictssurvivalassociatedprognosticgroupsinglioblastoma |